In the media

MS: new knowledge about stem cell treatment

Dagbladet.no

Bettina Husebø was awarded the dementia research prize for 2022

Dagensmedisin.no

Study: This could trigger MS

Dagbladet.no

NAD supplementation in Parkinson’s disease

Nature

Association of adverse childhood experiences with the development of multiple sclerosis

From the center

Otivio extends exploratory MS clinical trial with FlowOx

Uncategorized

Researchers in Bergen hope to slow down progression of Parkinsons with pill

NRK.NO

Encouraging results from our phase-I trial (NADPARK)

From the center

Can medicine weaken the human capacity to tolerate suffering?

From the center

Responding about stem cell treatment for MS patients

Dagensmedisin.no

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Dagensmedisin.no

Major funding for our Parkinson’s research from the Norwegian Health Authorities

From the center

Creativity & Innovation Leadership – Inspirational lectures and discussions with invited speakers Ole Dahlberg and Ingunn Johanne Ness.

From the center

Fiona Dick defending her PhD on studies of gene expression in the Parkinson’s disease brain

From the center

Three courses are available in the research school during the fall of 2021

From the center

Webinar about patient and public participation in clinical trials

From the center

Adjusting guidelines for MS treatment

Dagensmedisin.no

Neurodegenerative diseases remain an unsolved mystery

uib.no

Corticobasal degeneration (CBD)

Parkinsonforeningen

New website will help patients and health care personnel find clinical trials

Dagensmedisin.no

New trial: effective treatment for MS

Dagbladet.no

Rituximab shows good effect in follow-up study

Dagensmedisin.no

Research school cooperation between centres of excellence

uib.no

Norwegian researchers want to revolutionize treatment

NRK.NO

Important funding for MS trial

Dagensmedisin.no

When Siri dies, she wants to donate her brain

NRK.NO

Nye MS-pasienter skal få rituksimab eller okrelizumab i Bergen

Dagensmedisin.no

Her tennes håpet for ALS-syke Vivian (40)

TV2.NO

Hvorfor trenger vi mer hjerneforskning?

Dagensmedisin.no

In the lab

Forskningsdagene

Nytt hjernesenter gir Cathrine håp

Bt.no

Slik forsøker forskere å løse ALS gåten

Forskning.no

Moderne skyteknologi : – Vi er med på noe viktig

Uncategorized

Planlegger fire MS-studier

Dagensmedisin.no

Gir 149 millioner kroner til multisenter-studier

Dagensmedisin.no

Planlegger ALS-studie for 100 pasienter

Dagensmedisin.no

Wikipedia: Neuro-SysMed

Wikipedia.no

Åpnet Neuro-SysMed i Bergen

Dagensmedisin.no

Åpningen av Neuro-SysMed er viktig for hele hjerne-Norge

Dagensmedisin.no

Åpner nytt forskningssenter i Bergen: Slik skal de løse ALS-gåten

VG.NO

Nytt senter skal forske på demens

NRK.NO